8-K
filed May 7, 2026, 7:59 PM ET
ticker GRDN
CIK 0001802255
other
confidence high
sentiment neutral
materiality 0.15
Guardian Pharmacy holds 2026 annual meeting; all proposals pass
Guardian Pharmacy Services, Inc.
- Stockholders re-elected directors John Ackerman and Randall Lewis to Class II for three-year terms.
- Say-on-pay advisory vote approved with 53.8M for vs 500K against (98.9% support).
- Stockholders selected 1-year frequency for future say-on-pay votes; board will hold annual votes.
- Ratification of Ernst & Young as independent auditor for 2026 approved by 55.1M votes.
- About 910K broker non-votes on director elections and say-on-pay.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Guardian Pharmacy Services, Inc. shareholders approved Election of Class II Directors at the 2026-05-05 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-05
Exact text from the filing
The stockholders of the Company elected to the Company’s Board of Directors each of the Class II director nominees named below, to hold office until the Company’s annual meeting of stockholders to be held in 2029 and until their respective successors are duly elected and qualified.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Guardian Pharmacy Services, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-05 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-05
Exact text from the filing
The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Guardian Pharmacy Services, Inc. shareholders approved Approval, on a Non-Binding Advisory Basis, of the Frequency of the Company’s Future Advisory Votes to Approve the Compensation of the Company’s Named Executive Officers at the 2026-05-05 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2026-05-05
Exact text from the filing
The stockholders of the Company approved, on a non-binding advisory basis, a one-year frequency for the Company’s future advisory votes to approve the compensation of the Company’s named executive officers.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Guardian Pharmacy Services, Inc. shareholders approved Approval, on a Non-Binding Advisory Basis, of the Compensation of the Company’s Named Executive Officers at the 2026-05-05 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-05
Exact text from the filing
The stockholders of the Company approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers as described in the proxy statement for the Annual Meeting.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.